Sumit Aggarwal

2022

In 2022, Sumit Aggarwal earned a total compensation of $1.4M as Chief Executive Officer at Sevion Therapeutics, a 75% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$253,022
Option Awards$556,270
Salary$575,050
Other$11,600
Total$1,395,942

Aggarwal received $575.1K in salary, accounting for 41% of the total pay in 2022.

Aggarwal also received $253K in non-equity incentive plan, $556.3K in option awards and $11.6K in other compensation.

Rankings

In 2022, Sumit Aggarwal's compensation ranked 2,379th out of 5,694 executives tracked by ExecPay. In other words, Aggarwal earned more than 58.2% of executives.

ClassificationRankingPercentile
All
2,379
out of 5,694
58th
Division
Manufacturing
1,303
out of 3,099
58th
Major group
Chemicals And Allied Products
579
out of 1,406
59th
Industry group
Drugs
534
out of 1,307
59th
Industry
Biological Products, Except Diagnostic Substances
131
out of 291
55th
Source: SEC filing on April 28, 2023.

Aggarwal's colleagues

We found two more compensation records of executives who worked with Sumit Aggarwal at Sevion Therapeutics in 2022.

2022

Vijay Modur

Sevion Therapeutics

Head of Research and Development

2022

Daniel Geffken

Sevion Therapeutics

Chief Financial Officer

News

You may also like